Shares of Option Care Health, Inc. (OPCH) are rising more than 6% Monday morning at $30.68 after it affirmed that its proposed merger with Amedisys is still compelling.
The company stated this after Amedisys' disclosure of an unsolicited proposal from Optum.
"Our compelling all-stock transaction, expected to close in the second half of 2023, allows stockholders of both companies to participate in the upside of the combined company, which will be a differentiated leader in home health and alternate site care with unmatched scale and a unique cash flow profile." Option Care Health said.
Option Care expects that the merger with Amedisys will generate more than $500 million in annual cash flow by 2025 and more than $9 billion of combined revenue by 2027.
OPCH has traded in the range of $24.23 - $35.87 in the last 52 weeks.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.